Aberrant activation of TGF-β/ROCK1 enhances stemness during prostatic stromal hyperplasia
Cell Communication and Signaling · 06.05.2024 · 22 (1)
DOI: 10.1186/s12964-024-01644-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Communication and Signaling, online erschienen am 06.05.2024. Verfasst von Youyou Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China. Hauptthemen laut MEDLINE: rho-Associated Kinases, Prostatic Hyperplasia, Mesenchymal Stem Cells, Transforming Growth Factor beta. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation, Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University.
Abstract (Originalsprache)
Benign prostatic hyperplasia (BPH) is a multifactorial disease in which abnormal growth factor activation and embryonic reawakening are considered important factors. Here we demonstrated that the aberrant activation of transforming growth factor β (TGF-β)/Rho kinase 1 (ROCK1) increased the stemness of BPH tissue by recruiting mesenchymal stem cells (MSCs), indicating the important role of embryonic reawakening in BPH. When TGF-β/ROCK1 is abnormally activated, MSCs are recruited and differentiate into fibroblasts/myofibroblasts, leading to prostate stromal hyperplasia. Further research showed that inhibition of ROCK1 activation suppressed MSC migration and their potential for stromal differentiation. Collectively, our findings suggest that abnormal activation of TGF-β/ROCK1 regulates stem cell lineage specificity, and the small molecule inhibitor GSK269962A could target ROCK1 and may be a potential treatment for BPH. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China.
- Movement System Injury and Repair Research Center, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
- Movement System Injury and Repair Research Center, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China. huixie@csu.edu.cn.
- Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China. wanglong@csu.edu.cn.
Förderung
- National Natural Science Foundation
- Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University
Zitieren
APA
Li, Y., Li, J., Zhou, L., Wang, Z., Jin, L., Cao, J., Xie, H., & Wang, L. (2024). Aberrant activation of TGF-β/ROCK1 enhances stemness during prostatic stromal hyperplasia. Cell Communication and Signaling, 22(1). https://doi.org/10.1186/s12964-024-01644-4
Vancouver
Li Y, Li J, Zhou L, Wang Z, Jin L, Cao J, et al. Aberrant activation of TGF-β/ROCK1 enhances stemness during prostatic stromal hyperplasia. Cell Communication and Signaling. 2024;22(1). doi:10.1186/s12964-024-01644-4
BibTeX
@article{Li2024,
author = {Li, Youyou and Li, Jiaren and Zhou, Liang and Wang, Zhenxing and Jin, Ling and Cao, Jia and Xie, Hui and Wang, Long},
title = {Aberrant activation of TGF-β/ROCK1 enhances stemness during prostatic stromal hyperplasia},
journal = {Cell Communication and Signaling},
year = {2024},
volume = {22},
number = {1},
doi = {10.1186/s12964-024-01644-4}
}
EUVIMED